Get a glimpse into our company and investor data—powered by the PitchBook Platform
Rights to an abbreviated new drug application (ANDA). The ANDA rights concern Nystatin Oral suspension, a treatment for candidiasis in the oral cavity.
This information is reserved for PitchBook Platform users. To explore Bausch + Lomb (Abbreviated New Drug Application)‘s full profile, request access.
© 2019 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.